A Novel NanoDisc Platform for Systemic Targeting of Lymphoid Tissues and Induction of Antigen-Specific Immune Tolerance

Time: 12:30 pm
day: Day Two


  • Exploring how subcutaneous administration of NanoDisc targets multiple lymphoid tissues and immune system organs
  • NanoDisc carrying autoantigen induces antigen-specific Tregs and Tr1 cells
  • NanoDisc therapy exerts robust efficacy in preclinical models of Multiple Sclerosis and Type 1 Diabetes